As compared with the control group, which received no treatment, the staining of the cell proliferation marker Ki-67 significantly decreased in the tumor tissues after scFv S12 treatment, implying that the tumor growth was inhibited by immunomodulatory effects after scFv treatment (Figure 6(c)). This evidence concerns the gene MKI67 and neoplasm.